Utrecht, Netherlands

Edwin Johannes Adrianus Veldhuizen

This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Utrecht University. Active years: 2015-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edwin Johannes Adrianus Veldhuizen. Retrieved from https://idiyas.com/inventor/edwin-johannes-adrianus-veldhuizen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 80.0

 

 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2023

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Edwin Johannes Adrianus Veldhuizen: Innovator in Antimicrobial Peptides**

Introduction

Edwin Johannes Adrianus Veldhuizen, based in Utrecht, Netherlands, is a renowned inventor with a focus on advancements in antimicrobial peptides. With a total of five patents to his name, Veldhuizen is making significant contributions to the field of bioactive compounds aimed at enhancing human health through innovative solutions.

Latest Patents

Veldhuizen's latest patents include groundbreaking work on CATH2 derivatives, which provide new forms of cathelicidins aimed at preventing infections. These derivatives incorporate novel features such as N-terminally truncated peptides and cyclic peptides, offering promising applications as anti-infectives and vaccines, especially for in ovo applications. Additionally, he has developed antimicrobial peptides based on CMAP27, which demonstrate superior antimicrobial properties while exhibiting low hemolytic activity compared to the original CMAP27 peptide. These innovations are poised to play vital roles in antibiotic therapy and bacteriocidal compositions, alongside serving as adjuvants.

Career Highlights

Veldhuizen is currently associated with the University of Utrecht Holding B.V., where he spearheads research initiatives that bridge the gap between academic discoveries and practical applications in medicine. His work exemplifies a commitment to developing efficient antimicrobial treatments and advancing our understanding of immune responses.

Collaborations

Throughout his career, Veldhuizen has collaborated with notable coworkers such as Hendrik Peter Haagsman and Albert Van Dijk. These partnerships have fostered a productive research environment, leading to innovative solutions that address critical health challenges.

Conclusion

Edwin Johannes Adrianus Veldhuizen stands out as an inventor whose research is essential in the fight against infections through innovative antimicrobial peptides. His ongoing contributions to science and medicine are paving the way for new treatments and advancing our understanding of immune functions in the biomedical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…